140 related articles for article (PubMed ID: 2153401)
1. Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie SE; Maingay JP; Neill W
Br J Dermatol; 1990 Jan; 122(1):33-42. PubMed ID: 2153401
[TBL] [Abstract][Full Text] [Related]
2. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie S; Maingay J; Neill WA
Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
[TBL] [Abstract][Full Text] [Related]
3. The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection.
Otani T; Mori R
Arch Virol; 1987; 96(1-2):1-15. PubMed ID: 3039943
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative responses in recrudescent orofacial herpetic infections.
Vestey JP; Norval M; Howie SE
J R Soc Med; 1990 May; 83(5):308-11. PubMed ID: 2166159
[TBL] [Abstract][Full Text] [Related]
5. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
[TBL] [Abstract][Full Text] [Related]
6. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
7. Role of epidermal Langerhans cells in resistance to herpes simplex virus infection.
Yasumoto S; Okabe N; Mori R
Arch Virol; 1986; 90(3-4):261-71. PubMed ID: 3015083
[TBL] [Abstract][Full Text] [Related]
8. Murine epidermal antigen-presenting cells in primary and secondary T-cell proliferative responses to herpes simplex virus in vitro.
Williams NA; Hill TJ; Hooper DC
Immunology; 1991 Jan; 72(1):34-9. PubMed ID: 1847693
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet-B radiation induces modulation of antigen presentation of herpes simplex virus by human epidermal cells.
van der Molen RG; Out-Luiting C; Claas FH; Norval M; Koerten HK; Mommaas AM
Hum Immunol; 2001 Jun; 62(6):589-97. PubMed ID: 11390033
[TBL] [Abstract][Full Text] [Related]
10. Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response.
Lewandowski GA; Lo D; Bloom FE
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):2005-9. PubMed ID: 8095338
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 1 pathogenicity in footpad and ear skin of mice depends on Langerhans cell density, mouse genetics, and virus strain.
Sprecher E; Becker Y
J Virol; 1987 Aug; 61(8):2515-22. PubMed ID: 3037113
[TBL] [Abstract][Full Text] [Related]
12. Enriched epidermal Langerhans cells are potent antigen-presenting cells for T cells.
Bjercke S; Elgø J; Braathen L; Thorsby E
J Invest Dermatol; 1984 Oct; 83(4):286-9. PubMed ID: 6090538
[TBL] [Abstract][Full Text] [Related]
13. Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.
Akpek G; Joseph R; Günay C; Kessler II; Shvartsbeyn M; Bhatnagar B; Aurelian L
Biol Blood Marrow Transplant; 2013 Apr; 19(4):529-37. PubMed ID: 23313704
[TBL] [Abstract][Full Text] [Related]
14. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
[TBL] [Abstract][Full Text] [Related]
15. Role of Langerhans cells and Thy. 1+ effector cells in herpes simplex virus-1 infection in the skin of newborn mice.
Sprecher E; Becker Y
Arch Virol; 1988; 100(3-4):285-92. PubMed ID: 3261161
[TBL] [Abstract][Full Text] [Related]
16. Immunity to herpes simplex virus type 2: viral antigen-presenting capacity of epidermal cells and its impairment by ultraviolet irradiation.
Hayashi Y; Aurelian L
J Immunol; 1986 Feb; 136(3):1087-92. PubMed ID: 3001186
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
18. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
McKenna DB; Neill WA; Norval M
Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
